NCT02145858View on ClinicalTrials.gov

Prevention of Retained-Blood Outcomes With Active Clearance Technology

CompletedOBSERVATIONAL
Enrollment

891

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

July 31, 2016

Study Completion Date

November 30, 2016

Conditions
HemorrhageAtrial Fibrillation, Postoperative
Interventions
DEVICE

Blood drainage post cardiac surgery using PleuraFlow System

Trial Locations (2)

03102

Catholic Medical Center, Manchester

37232-8802

Vanderbilt University Medical Center, Nashville

Sponsors

Lead Sponsor

ClearFlow, Inc.

Collaborators (1)

Catholic Medical Center
All Listed Sponsors
collaborator

Vanderbilt University Medical Center

OTHER

collaborator

Catholic Medical Center

OTHER

lead

ClearFlow, Inc.

INDUSTRY

NCT02145858 - Prevention of Retained-Blood Outcomes With Active Clearance Technology | Biotech Hunter | Biotech Hunter